Colgate-Palmolive Stock Forecast, Price & News

11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Colgate-Palmolive in the last twelve months. There are currently 2 sell ratings, 6 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Colgate-Palmolive stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CL, but not buy additional shares or sell existing shares.
View analyst ratings for Colgate-Palmolive or view top-rated stocks.

Wall Street analysts have given Colgate-Palmolive a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Colgate-Palmolive wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Colgate-Palmolive saw a increase in short interest in January. As of January 29th, there was short interest totaling 8,650,000 shares, an increase of 29.9% from the January 14th total of 6,660,000 shares. Based on an average daily trading volume, of 4,040,000 shares, the short-interest ratio is currently 2.1 days. Approximately 1.0% of the shares of the company are short sold.
View Colgate-Palmolive's Short Interest.

Colgate-Palmolive is scheduled to release its next quarterly earnings announcement on Friday, May 7th 2021.
View our earnings forecast for Colgate-Palmolive.

Colgate-Palmolive (NYSE:CL) posted its quarterly earnings data on Thursday, January, 28th. The company reported $0.77 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.76 by $0.01. The company earned $4.32 billion during the quarter, compared to the consensus estimate of $4.15 billion. Colgate-Palmolive had a net margin of 16.65% and a trailing twelve-month return on equity of 383.88%. The firm's quarterly revenue was up 7.7% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.73 EPS.
View Colgate-Palmolive's earnings history.

Colgate-Palmolive's stock was trading at $68.90 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CL stock has increased by 9.9% and is now trading at $75.73.
View which stocks have been most impacted by COVID-19.

Colgate-Palmolive declared a quarterly dividend on Thursday, January 14th. Investors of record on Monday, January 25th will be paid a dividend of $0.44 per share on Tuesday, February 16th. This represents a $1.76 annualized dividend and a yield of 2.32%. The ex-dividend date is Friday, January 22nd.
View Colgate-Palmolive's dividend history.

Colgate-Palmolive pays an annual dividend of $1.76 per share and currently has a dividend yield of 2.30%. Colgate-Palmolive has been increasing its dividend for 59 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Colgate-Palmolive is 62.19%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Colgate-Palmolive will have a dividend payout ratio of 53.99% next year. This indicates that Colgate-Palmolive will be able to sustain or increase its dividend.
View Colgate-Palmolive's dividend history.

Colgate-Palmolive updated its FY 2021 Pre-Market earnings guidance on Friday, January, 29th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $17.13-17.624 billion, compared to the consensus revenue estimate of $16.96 billion.

11 brokers have issued twelve-month target prices for Colgate-Palmolive's stock. Their forecasts range from $76.00 to $90.00. On average, they anticipate Colgate-Palmolive's share price to reach $81.91 in the next twelve months. This suggests a possible upside of 8.2% from the stock's current price.
View analysts' price targets for Colgate-Palmolive or view top-rated stocks among Wall Street analysts.

195 employees have rated Colgate-Palmolive CEO Noel Wallace on Glassdoor.com. Noel Wallace has an approval rating of 95% among Colgate-Palmolive's employees. This puts Noel Wallace in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to Colgate-Palmolive include The Procter & Gamble (PG), Kimberly-Clark (KMB), The Clorox (CLX), Church & Dwight (CHD), WD-40 (WDFC), Spectrum Brands (SPB), Central Garden & Pet (CENTA), Oil-Dri Co. of America (ODC) and Orchids Paper Products (TIS).
View all of CL's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Colgate-Palmolive investors own include Johnson & Johnson (JNJ), The Procter & Gamble (PG), AT&T (T), AbbVie (ABBV), PepsiCo (PEP), Verizon Communications (VZ), The Coca-Cola (KO), Intel (INTC), McDonald's (MCD) and The Walt Disney (DIS).

Colgate-Palmolive trades on the New York Stock Exchange (NYSE) under the ticker symbol "CL."

Colgate-Palmolive's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (6.78%), Bank of New York Mellon Corp (2.18%), Northern Trust Corp (1.22%), Charles Schwab Investment Management Inc. (0.80%), Price T Rowe Associates Inc. MD (0.72%) and Nuveen Asset Management LLC (0.69%). Company insiders that own Colgate-Palmolive stock include Daniel B Marsili, Helene D Gayle, Henning I Jakobsen, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, John W Kooyman, Justin Skala, Michael B Polk, Noel R Wallace, Panagiotis Tsourapas, Patricia Verduin, Philip G Shotts, Prabha Parameswaran, Sally Massey and Stephen I Sadove.
View institutional ownership trends for Colgate-Palmolive.

CL stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Renaissance Technologies LLC, LGT Capital Partners LTD., Caisse DE Depot ET Placement DU Quebec, Sumitomo Mitsui Trust Holdings Inc., State of Wisconsin Investment Board, Alliancebernstein L.P., and The Manufacturers Life Insurance Company . Company insiders that have sold Colgate-Palmolive company stock in the last year include Daniel B Marsili, Henning I Jakobsen, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, John W Kooyman, Michael B Polk, Noel R Wallace, Panagiotis Tsourapas, Patricia Verduin, Philip G Shotts, and Sally Massey.
View insider buying and selling activity for Colgate-Palmolive or view top insider-selling stocks.

CL stock was bought by a variety of institutional investors in the last quarter, including American International Group Inc., Morgan Stanley, Lazard Freres Gestion S.A.S., Bank of New York Mellon Corp, KAMES CAPITAL plc, Canada Pension Plan Investment Board, Skandinaviska Enskilda Banken AB publ , and Schroder Investment Management Group.
View insider buying and selling activity for Colgate-Palmolive or or view top insider-buying stocks.

Shares of CL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CL stock can currently be purchased for approximately $75.73.

Colgate-Palmolive has a market capitalization of $64.26 billion and generates $15.69 billion in revenue each year. The company earns $2.37 billion in net income (profit) each year or $2.83 on an earnings per share basis.

Colgate-Palmolive employs 34,300 workers across the globe.

The official website for Colgate-Palmolive is www.colgatepalmolive.com.

Colgate-Palmolive is headquartered at 300 PARK AVE, NEW YORK NY, 10022.

Colgate-Palmolive's mailing address is 300 PARK AVE, NEW YORK NY, 10022. The company can be reached via phone at 212-310-2000 or via email at [email protected]